The Latest Cardiac and Vascular News
NEW YORK–(BUSINESS WIRE)–JLL Partners (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in the healthcare, industrials and business services sectors, announced today the final close of JLL Partners Fund IX, L.P. (“Fund IX” or the “Fund”) with approximately $1.4 billion in equity commitments. […]
Greg Groenke Appointed CEO; Lars Marcher Named Executive Chairman NEW YORK–(BUSINESS WIRE)–JLL Partners (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in the healthcare, aerospace and defense, and business services sectors, today announced its investment in Vascular Technology, Incorporated (“VTI” or the “Company”), a […]
HeartLight® X3 Japan Launch Anticipated in Mid-2021 MARLBOROUGH, Mass., Feb. 2, 2021 /PRNewswire/ — CardioFocus, Inc., a medical device company dedicated to advancing ablation treatments for atrial fibrillation (AFib), announced today that it has expanded its existing partnership agreement with Japan Lifeline Co., Ltd. (JLL). The agreement extends the timeframe of the existing distribution […]
